Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:694 (24 September), doi:10.1136/bmj.331.7518.694-a
| The first 150 words of the full text of this article appear below. |
EDITORI was intrigued by the five scenarios of the International Campaign to Revitalise Academic Medicine.1 Certainly, brainstorming over the future of academic medicine is a fascinating exercise. But, aside from revealing facets of the interaction of medicine in general with (global) society, it is sterile.
Academic medicinemeaning the entirety of academic institutions globallyis heterogeneous and will certainly evolve differently in different societies as a function of local issues and cultures. But, most importantly, in any given location it will evolve in response to its sources of revenue, which are quite varied.
In the large private universities of the United States major funding comes from research grants (federal, pharmaceutical, and philanthropic) and only a small fraction (5-10%) from student tuition. As donors' budget priorities change, so will academic priorities, as will the direction of the academic enterprise.
Certainly, medical schools will remain committed to a basic curriculum of human
Mark G Perlroth, professor of medicine
Stanford University, CA 94305, USA mgp@stanford.edu